Further single-cell sequencing analyses in five cancers (BLCA, GBM, HNSC, KIRC and GBM) indicated that PODNL1 was highly expressed in cancer cells in all included cancers as well as in CAFs of BLCA and HNSC. Here, PODNL1 is linked to bladder transitional cell carcinoma.